These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 36864821)

  • 1. Sarecycline inhibits protein translation in Cutibacterium acnes 70S ribosome using a two-site mechanism.
    Lomakin IB; Devarkar SC; Patel S; Grada A; Bunick CG
    Nucleic Acids Res; 2023 Apr; 51(6):2915-2930. PubMed ID: 36864821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microbiological Profile of Sarecycline, a Novel Targeted Spectrum Tetracycline for the Treatment of Acne Vulgaris.
    Zhanel G; Critchley I; Lin LY; Alvandi N
    Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30397052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sarecycline interferes with tRNA accommodation and tethers mRNA to the 70S ribosome.
    Batool Z; Lomakin IB; Polikanov YS; Bunick CG
    Proc Natl Acad Sci U S A; 2020 Aug; 117(34):20530-20537. PubMed ID: 32817463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanistic basis for the translation inhibition of Cutibacterium acnes by Clindamycin.
    Lomakin IB; Devarkar SC; Grada A; Bunick CG
    J Invest Dermatol; 2024 Aug; ():. PubMed ID: 39122144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sarecycline hydrochloride for the treatment of acne vulgaris.
    Kaul G; Saxena D; Dasgupta A; Chopra S
    Drugs Today (Barc); 2019 Oct; 55(10):615-625. PubMed ID: 31720559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibiotic resistant Cutibacterium acnes among acne patients in Jordan: a cross sectional study.
    Alkhawaja E; Hammadi S; Abdelmalek M; Mahasneh N; Alkhawaja B; Abdelmalek SM
    BMC Dermatol; 2020 Nov; 20(1):17. PubMed ID: 33203374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sarecycline: a narrow spectrum tetracycline for the treatment of moderate-to-severe acne vulgaris.
    Moore AY; Charles JEM; Moore S
    Future Microbiol; 2019 Sep; 14(14):1235-1242. PubMed ID: 31475868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advances in understanding
    Platsidaki E; Dessinioti C
    F1000Res; 2018; 7():. PubMed ID: 30613388
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Boyanova L
    Future Microbiol; 2023 Mar; 18():235-244. PubMed ID: 37042433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibiotics and Antimicrobial Resistance in Acne: Epidemiological Trends and Clinical Practice Considerations.
    Dessinioti C; Katsambas A
    Yale J Biol Med; 2022 Dec; 95(4):429-443. PubMed ID: 36568833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cutibacterium acnes: Much ado about maybe nothing much.
    van Steensel MAM; Goh BC
    Exp Dermatol; 2021 Oct; 30(10):1471-1476. PubMed ID: 34009698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimicrobial Susceptibility of
    Solís MB; Zurita J; Velasco N; Dressendorfer LM
    Skinmed; 2018; 16(3):159-165. PubMed ID: 29989535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Propionibacterium acnes and antimicrobial resistance in acne.
    Dessinioti C; Katsambas A
    Clin Dermatol; 2017; 35(2):163-167. PubMed ID: 28274353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Shiunko and Chuoko, topical Kampo medicines, inhibit the expression of gehA encoding the extracellular lipase in Cutibacterium acnes.
    Nakase K; Tashiro A; Yamada T; Ikoshi H; Noguchi N
    J Dermatol; 2019 Apr; 46(4):308-313. PubMed ID: 30803018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lactobacillus paraplantarum THG-G10 as a potential anti-acne agent with anti-bacterial and anti-inflammatory activities.
    Cha H; Kim SK; Kook M; Yi TH
    Anaerobe; 2020 Aug; 64():102243. PubMed ID: 32712375
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Bronnec V; Eilers H; Jahns AC; Omer H; Alexeyev OA
    Front Cell Infect Microbiol; 2021; 11():809792. PubMed ID: 35155271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparative study of Cutibacterium (Propionibacterium) acnes clones from acne patients and healthy controls.
    Lomholt HB; Scholz CFP; Brüggemann H; Tettelin H; Kilian M
    Anaerobe; 2017 Oct; 47():57-63. PubMed ID: 28434779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PEG-8 Laurate Fermentation of
    Marito S; Keshari S; Huang CM
    Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32707723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Avidumicin, a novel cyclic bacteriocin, produced by Cutibacterium avidum shows anti-Cutibacterium acnes activity.
    Koizumi J; Nakase K; Noguchi N; Nakaminami H
    J Antibiot (Tokyo); 2023 Sep; 76(9):511-521. PubMed ID: 37264118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibiotic Resistance Risk with Oral Tetracycline Treatment of Acne Vulgaris.
    Swallow MA; Fan R; Cohen JM; Bunick CG
    Antibiotics (Basel); 2022 Jul; 11(8):. PubMed ID: 36009899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.